Pathway uncovered for greatest lupus genetic risk factor, study shows

The discovery could be a route to novel treatments for the autoimmune disease.

5:00 AM

Author | Noah Fromson

Microscope lab notes
Jacob Dwyer, Justine Ross, Michigan Medicine

Researchers at Michigan Medicine have uncovered the molecular mechanism that drives the disease-causing effects of the most common genetic risk factor for lupus, a study suggests.

Systemic lupus erythematosus is a common, incurable autoimmune disease that affects millions of individuals worldwide, with a particularly high prevalence among women. A genetic variant, called HLA-DRB1*03:01, is the greatest risk factor for the condition, which involves inflammation in many vital organs, and can lead to severe disability and death.

In a study recently published in communications biology (a Nature Portfolio journal), investigators found that a protein coded by that HLA variant triggers a cascade of molecular and cellular effects that can cause the inflammatory symptoms seen in lupus patients.

"For the first time, we have found the enigmatic mechanism that genetically predisposes people to the worst effects of the most typical form of lupus," said Joseph Holoshitz, M.D., senior author of the paper and professor of internal medicine and rheumatology at University of Michigan Medical School. "The findings could potentially facilitate the discovery of safe, simple and effective treatments for SLE by targeting this new pathway."

The results support a novel theory how genetic variants of the kind of HLA-DRB1*03:01 can lead to autoimmune diseases independent of antigen presentation, the traditionally studied mechanism, which has been long proposed but, so far, not directly proven.

"We have identified a chain of events in cell culture, as well as a mouse model of the disease, that demonstrate how the abnormalities that can cause lupus develop from the first effect of the risk gene, to signaling, all the way to immune abnormalities and clinical manifestations of lupus," said Bruna Miglioranza Scavuzzi, Ph.D., first author of the paper and a postdoctoral research fellow in the Division of Rheumatology at the University of Michigan Medical School.

The findings of this study are reminiscent of previous findings in rheumatoid arthritis, another HLA-associated disease, that have paved the way for the development of small molecules to effectively treat arthritis in mice, Holoshitz says.

"Human trials in RA with those compounds are being carried out, and I hope that our novel findings will lead to similar efforts to ease the burden of millions of lupus patients as well," he said.

Additional authors include Vincent van Drongelen, Ph.D., Bhavneet Kaur, Ph.D., Jennifer Callahan Fox, M.S., Jianhua Liu, Ph.D., Raquel A. Mesquita-Ferrari, Ph.D., J. Michelle Kahlenberg, M.D., Ph.D., Amr H. Sawalha, M.D., Evan A. Farkash, M.D., all of Michigan Medicine, Fernando Benavides, Ph.D., MD Anderson Cancer Center, Frederick W. Miller, M.D., Ph.D., National Institute of Environmental Health Sciences, Amr H. Sawalha, University of Pittsburgh.

Paper cited: "The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope," communications biology. DOI: 10.1038/s42003-022-03717-x

More Articles About: Lab Notes Lupus Genetics Basic Science and Laboratory Research Rheumatology
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.
A family discussing their family's medical history at Thanksgiving
Health Lab
Why you need to discuss your family health history at Thanksgiving
The holidays are a great time to discuss your family's medical history. Learn the importance of discussing your family's health history & how to bring it up.
doctor with patient white and black patient ignored
Health Lab
Fixing racial inequities in lupus care
When it comes to lupus care, Black adults are normally left behind despite being one of the highest lupus populations.
Health Lab
Managing scleroderma symptoms through a team approach
Research published in the Arthritis Care and Research Journal from Michigan Medicine found that scleroderma patients made significant strides when working with trained peer health coaches in adhering to wellness routines, leading to resilience and improvements in fatigue, pain and depressive symptoms.
white bowls with allergens in each one
Health Lab
Measuring skin water loss predicts anaphylaxis during food allergy tests
Measuring skin water loss during food allergy tests may help predict anaphylaxis and keep patients safe. The method aims to detect the life threatening reaction before epinephrine injections are necessary
grey needle into cell blue
Health Lab
Mouse model of gender-affirming testosterone treatment and fertility finds decrease in egg yield but not quality
The current IVF recommendation is for transgender patients to stop taking gender-affirming hormones before the procedure, which can be costly and life changing. Now, a team of researchers are diving in further to investigate what the best recommendations should be based on more evidence.